Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (3) : biotech industry

CordenPharma to Acquire AmbioPharm to Expand Peptide Manufacturing Platform

CordenPharma to Acquire AmbioPharm to Expand Peptide Manufacturing Platform
05/27/2026 | Companies
CordenPharma has announced plans to acquire AmbioPharm, a move aimed at strengthening its peptide active pharmaceutical ingredient (API) manufacturing capabilities and expanding its global production network. The acquisition will enhance CordenPharma’s existing peptide platform by adding...
AmbioPharm, API manufacturing, Astorg, biopharmaceuticals, biotech industry, BNP Paribas, Carlyle Group, CDMO, China pharmaceutical manufacturing, clinical peptide supply, commercial peptide production, contract development and manufacturing organization, CordenPharma, global peptide supply, hybrid peptide synthesis, LPPS, North Augusta facility, peptide API, peptide APIs, peptide commercialization, peptide drug development, peptide manufacturing, peptide medicines, peptide platform, pharmaceutical acquisition, pharmaceutical industry, pharmaceutical manufacturing, Shanghai manufacturing, SPPS, TAPS technology, U.S. peptide manufacturing

Belief BioMed & Grand Life Sciences Partner to Advance Hemophilia A Gene Therapy in China

Belief BioMed & Grand Life Sciences Partner to Advance Hemophilia A Gene Therapy in China
03/23/2026 | Companies
Belief BioMed (“BBM”) and Grand Life Sciences Group Co., Ltd. (“Grand Life Sciences”) have entered into an exclusive partnership agreement. As part of the deal, Belief BioMed will provide Grand Life Sciences with commercialization rights for its investigational therapy, BBM-H803, across Mainland...
BBM-H803, BBM-H901, Belief BioMed, biotech industry, biotechnology partnership, China healthcare, clinical development, commercialization rights, drug development, gene therapy, Grand Life Sciences, healthcare innovation, hematology, hemophilia A, hemophilia treatment, innovative therapies, medical research, pharmaceutical collaboration, rare diseases

Merck recognized as one of America’s Most Just companies

Merck recognized as one of America’s Most Just companies
01/19/2023 | Companies
Merck, known as MSD outside of the United States and Canada, was named one of America's Most JUST Companies for the sixth year in a row, marking the company's dedication to its employees, customers, communities, the environment, and shareholders. Merck was ranked No. 26 overall and No. 1 in the...
biotech industry, communities, customers, employees, environment, Merck, Most JUST Companies 2023, pharmaceuticals, recognition, shareholders, stakeholders


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com